Anteris Technologies Global (AVR) Competitors $4.27 -0.16 (-3.61%) As of 02:29 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock AVR vs. SIBN, BVS, AVNS, ZIMV, KIDS, BFLY, CBLL, TMCI, SMLR, and DCTHShould you be buying Anteris Technologies Global stock or one of its competitors? The main competitors of Anteris Technologies Global include SiBone (SIBN), Bioventus (BVS), Avanos Medical (AVNS), ZimVie (ZIMV), OrthoPediatrics (KIDS), Butterfly Network (BFLY), CeriBell (CBLL), Treace Medical Concepts (TMCI), Semler Scientific (SMLR), and Delcath Systems (DCTH). These companies are all part of the "medical equipment" industry. Anteris Technologies Global vs. Its Competitors SiBone Bioventus Avanos Medical ZimVie OrthoPediatrics Butterfly Network CeriBell Treace Medical Concepts Semler Scientific Delcath Systems Anteris Technologies Global (NASDAQ:AVR) and SiBone (NASDAQ:SIBN) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, profitability, risk, institutional ownership, dividends, media sentiment, valuation and earnings. Do insiders and institutionals have more ownership in AVR or SIBN? 98.1% of SiBone shares are held by institutional investors. 4.0% of Anteris Technologies Global shares are held by company insiders. Comparatively, 4.0% of SiBone shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Is AVR or SIBN more profitable? Anteris Technologies Global has a net margin of 0.00% compared to SiBone's net margin of -12.83%. Anteris Technologies Global's return on equity of 0.00% beat SiBone's return on equity.Company Net Margins Return on Equity Return on Assets Anteris Technologies GlobalN/A N/A N/A SiBone -12.83%-14.20%-10.38% Which has higher valuation & earnings, AVR or SIBN? SiBone has higher revenue and earnings than Anteris Technologies Global. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAnteris Technologies Global$2.70M56.36-$76.29MN/AN/ASiBone$185.26M3.30-$30.91M-$0.56-25.29 Does the media refer more to AVR or SIBN? In the previous week, Anteris Technologies Global had 2 more articles in the media than SiBone. MarketBeat recorded 4 mentions for Anteris Technologies Global and 2 mentions for SiBone. SiBone's average media sentiment score of 1.91 beat Anteris Technologies Global's score of 0.71 indicating that SiBone is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Anteris Technologies Global 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SiBone 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Do analysts recommend AVR or SIBN? Anteris Technologies Global presently has a consensus target price of $16.50, suggesting a potential upside of 291.00%. SiBone has a consensus target price of $23.67, suggesting a potential upside of 67.08%. Given Anteris Technologies Global's higher possible upside, research analysts clearly believe Anteris Technologies Global is more favorable than SiBone.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Anteris Technologies Global 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00SiBone 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryAnteris Technologies Global beats SiBone on 7 of the 11 factors compared between the two stocks. Get Anteris Technologies Global News Delivered to You Automatically Sign up to receive the latest news and ratings for AVR and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding AVR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AVR vs. The Competition Export to ExcelMetricAnteris Technologies GlobalMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$152.17M$6.51B$5.65B$10.30BDividend YieldN/A1.20%5.68%4.61%P/E RatioN/A25.0475.7126.17Price / Sales56.36197.65514.12169.29Price / CashN/A21.7937.5661.52Price / Book2.435.0312.926.31Net Income-$76.29M$178.07M$3.29B$270.94M7 Day Performance-21.85%-2.17%-0.14%0.11%1 Month Performance14.05%5.25%3.97%6.67%1 Year PerformanceN/A21.81%68.37%28.91% Anteris Technologies Global Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AVRAnteris Technologies Global1.6424 of 5 stars$4.27-3.6%$16.50+286.4%N/A$153.98M$2.70M0.00138SIBNSiBone3.7906 of 5 stars$14.60-3.8%$23.67+62.1%-1.5%$629.86M$185.26M-26.07350Positive NewsBVSBioventus1.1697 of 5 stars$6.93-3.8%N/AN/A$572.97M$573.28M13.861,200News CoverageAVNSAvanos Medical1.8558 of 5 stars$11.92-2.9%N/A-49.0%$553.11M$692.50M-1.182,227Positive NewsHigh Trading VolumeZIMVZimVie1.2775 of 5 stars$18.91+0.1%$17.75-6.1%+18.9%$533.45M$449.75M-27.011,770KIDSOrthoPediatrics4.4073 of 5 stars$19.18-4.6%$34.14+78.0%-30.5%$480.84M$204.73M-10.72200Positive NewsBFLYButterfly Network3.2957 of 5 stars$1.86-1.9%$3.00+61.7%+26.5%$466.98M$87.52M-6.63460High Trading VolumeCBLLCeriBell2.1257 of 5 stars$12.25-2.5%$32.14+162.4%N/A$449.09M$65.44M-4.10N/AHigh Trading VolumeTMCITreace Medical Concepts2.3451 of 5 stars$6.89-4.2%$9.83+42.7%+24.9%$435.24M$209.36M-8.72250Positive NewsSMLRSemler Scientific2.8912 of 5 stars$29.18-1.1%$78.00+167.3%+38.6%$432.01M$42.98M12.01120Trending NewsAnalyst ForecastGap DownDCTHDelcath Systems2.5929 of 5 stars$11.54-1.8%$24.50+112.3%+23.4%$403.68M$70.24M230.8060Positive News Related Companies and Tools Related Companies SIBN Alternatives BVS Alternatives AVNS Alternatives ZIMV Alternatives KIDS Alternatives BFLY Alternatives CBLL Alternatives TMCI Alternatives SMLR Alternatives DCTH Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AVR) was last updated on 9/25/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Anteris Technologies Global Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Anteris Technologies Global With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
